NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/20/2024
Back to search
Official data from USPTO
LUVANTAS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/20/2024
Trademark type
Word
Nice classes
5
Filing date
12/13/2022
Registration date
08/20/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/20/2024
Last transaction
08/20/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
Chungcheongbuk-do, KR
Examiner
BRYANT, ALEXANDRIA
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Medytox Inc.
Representatives
Mark J. Liss LEYDIG, VOIT & MAYER, LTD.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Implantable medicines for treating neurological disorders and muscle dystonia; implantable antiaging medicinesbotulinum toxin for medical use for treatment of facial wrinkles; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar linesforehead wrinkleslateral canthal linemigraine headacheoveractive bladderurge incontinenceprostate disordercervical dystoniaspasticitymuscle dystoniablepharospasmhyperhidrosisstrabismusexcessive eye blinkingneuropathy pain and pelvic pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar linesforehead wrinkleslateral canthal linemigraine headacheoveractive bladderurge incontinenceprostate disordercervical dystoniaspasticitymuscle dystoniablepharospasmhyperhidrosisstrabismusexcessive eye blinkingneuropathy pain and pelvic pain
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2024
PUBO
PUBLISHED FOR OPPOSITION
06/04/2024
ATRV
ATTORNEY REVIEW COMPLETED
05/29/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/15/2024
OTHE
CASE RETURNED TO EXAMINATION
05/02/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
05/02/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/25/2024
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
04/25/2024
APET
ASSIGNED TO PETITION STAFF
04/23/2024
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
03/29/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/23/2024
EX1G
SOU EXTENSION 1 GRANTED
01/19/2024
EXT1
SOU EXTENSION 1 FILED
01/19/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/19/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/25/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/30/2023
PUBO
PUBLISHED FOR OPPOSITION
05/30/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/21/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/21/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/21/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/05/2023
GNRT
NON-FINAL ACTION E-MAILED
01/05/2023
CNRT
NON-FINAL ACTION WRITTEN
01/05/2023
DOCK
ASSIGNED TO EXAMINER
12/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/16/2022
NWAP
NEW APPLICATION ENTERED
12/16/2022
Continuous trademark protection
Get notified about every new filing that threatens LUVANTAS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.